| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/14/2002 | WO2002020037A1 Biologically active oral preparation that can be site-specific released in colon |
| 03/14/2002 | WO2002020035A1 Hla binding peptides and their uses |
| 03/14/2002 | WO2002020031A2 Use of erythropoietin and the derivatives of the same for treating schizophrenia and related psychoses |
| 03/14/2002 | WO2002020026A2 Treatment of drug resistant organisms with nitric oxide |
| 03/14/2002 | WO2002020025A1 Helium-oxygen mixture with therapeutic application |
| 03/14/2002 | WO2002020018A1 Tablets containing epinastine manufactured by direct compression |
| 03/14/2002 | WO2002019999A2 Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant |
| 03/14/2002 | WO2002019993A1 Granular preparations for oral administration |
| 03/14/2002 | WO2002019992A2 Switchable tackiness coating compositions for ophthalmic implants |
| 03/14/2002 | WO2002019991A1 Multiparticulate pharmaceutical dosage form and a method for producing the same |
| 03/14/2002 | WO2002019990A1 Modified release formulation |
| 03/14/2002 | WO2002019989A2 Alginate particle formulation |
| 03/14/2002 | WO2002019988A2 Sustained release particle dispersion |
| 03/14/2002 | WO2002019987A1 Dry-powder film coating composition and method of preparation |
| 03/14/2002 | WO2002019986A1 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 03/14/2002 | WO2002019985A2 Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure |
| 03/14/2002 | WO2002019972A2 Stabilized ascorbic acid solutions |
| 03/14/2002 | WO2002019969A2 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
| 03/14/2002 | WO2002019961A2 Pharmaceutical compositions for headache, migraine, nausea and emesis |
| 03/14/2002 | WO2001093890A3 Botulinum toxin implant |
| 03/14/2002 | WO2001093827A3 Neurotoxin implant |
| 03/14/2002 | WO2001082866A3 Cosmetic compositions containing film forming polymers plasticized with esters of malic acid |
| 03/14/2002 | WO2001078696A3 Formulations for use in inhaler devices |
| 03/14/2002 | WO2001078695A3 Pharmaceutical formulations for dry powder inhalers |
| 03/14/2002 | WO2001078694A3 Formulations for use in inhaler devices |
| 03/14/2002 | WO2001076644A3 Lipid-based systems for targeting diagnostic agents |
| 03/14/2002 | WO2001076555A3 Lipid-based drug delivery systems for topical application |
| 03/14/2002 | WO2001066093A3 Sustained release ranolazine formulations |
| 03/14/2002 | WO2001066081A3 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
| 03/14/2002 | WO2001064163A3 An improved herbal composition having antiallergic properties and a process for the preparation thereof |
| 03/14/2002 | WO2001064046A3 Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof |
| 03/14/2002 | WO2001062774A3 Purified lh |
| 03/14/2002 | WO2001062374A3 Method for producing nanosuspensions |
| 03/14/2002 | WO2001062240A3 Use of zwitterion-type detergent for preparing a pharmaceutical composition for nasal delivery |
| 03/14/2002 | WO2001061007A3 Fibroblast growth factor-23 molecules and uses thereof |
| 03/14/2002 | WO2001058918A3 Oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments |
| 03/14/2002 | WO2001052897A3 Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitors |
| 03/14/2002 | WO2001052826A3 Novel podophyllotoxin compositions |
| 03/14/2002 | WO2001051512A3 Human and parasite orphan receptor proteins |
| 03/14/2002 | WO2001049264A3 Pharmaceutical compositions for oral administration |
| 03/14/2002 | WO2001049256A3 Oil-free cosmetic or dermatological preparations containing solid and liquid uv filter substances |
| 03/14/2002 | WO2001047551A3 Eliciting antibodies specific for hepatitis c virus (hcv) |
| 03/14/2002 | WO2001045743A3 Use of an enzyme to improve the resorption of medicaments in the tissue |
| 03/14/2002 | WO2001041706A3 Lipid nanotubules for topical delivery |
| 03/14/2002 | WO2001034113A3 Apparatus and method for preparing microparticles |
| 03/14/2002 | WO2001032161A3 Use of a hmg-coa reductase inhibitor for treating amyloid beta precursor disorders |
| 03/14/2002 | WO2001032130A3 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 03/14/2002 | US20020032476 Flexible vascular inducing implants |
| 03/14/2002 | US20020032401 Osmotic beneficial agent delivery system |
| 03/14/2002 | US20020032325 4-amino-3-mercapto-1,2,4-triazoles |
| 03/14/2002 | US20020032254 Hydrophobic polymer dispersion and process for the preparation thereof |
| 03/14/2002 | US20020032243 Novel inverse latices self-invertible with respect to fatty acid esters, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising them |
| 03/14/2002 | US20020032240 Preferably administered along with a basic permeation enhancer and a hydroxide-releasing agent such as sodium hydroxide. |
| 03/14/2002 | US20020032234 First fatty acid compound that is a linoleic or linolenic compound and a second fatty acid that is a docosahexaenoic acid compound, an omega-3 or an omega-2 fatty acid or derivative |
| 03/14/2002 | US20020032231 Viscous gel |
| 03/14/2002 | US20020032229 Novel compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 03/14/2002 | US20020032220 The solutions are used to fill capsules, or self-supporting solid solutions are shaped into solid dosage forms such as tablets or pellets. |
| 03/14/2002 | US20020032217 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 03/14/2002 | US20020032212 A tricyclic compound (with oxy and nitrogen atoms in the ring); perticularly useful for treating or preventing psoriasis and other skin diseases |
| 03/14/2002 | US20020032201 Compositions containing alpha-2-adrenergic agonist components |
| 03/14/2002 | US20020032197 Methods and compositions for using moclobemide |
| 03/14/2002 | US20020032188 Compositions and methods for treatment of anal fissure |
| 03/14/2002 | US20020032181 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 03/14/2002 | US20020032180 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 03/14/2002 | US20020032171 Solubilization of triglycerides, drug delivery |
| 03/14/2002 | US20020032170 Underivatized, aqueous soluble beta (1-3) glucan, composition and method of making same |
| 03/14/2002 | US20020032166 Biocompatible cationic detergents and uses therefor |
| 03/14/2002 | US20020032165 Microspheres and adjuvants for DNA vaccine delivery |
| 03/14/2002 | US20020032164 For sanitizing surfaces |
| 03/14/2002 | US20020032159 Lyophilized compositions containing sphingoglycolipid and process for preparing them |
| 03/14/2002 | US20020031763 Complexing |
| 03/14/2002 | US20020031559 Antiallergens |
| 03/14/2002 | US20020031558 Preparation of aqueous clear solution dosage forms with bile acids |
| 03/14/2002 | US20020031556 Mixture of acid, tin pyrophosphate, salicylic acid and glycerides |
| 03/14/2002 | US20020031553 Manufacturing process of microcapsules for sustained release of water soluble peptides |
| 03/14/2002 | US20020031552 Teste masked pharmaceutical particles |
| 03/14/2002 | US20020031551 Bioerodable polymeric adhesives for tissue repair |
| 03/14/2002 | US20020031550 Nervous system disorders; Alzheimer's disease |
| 03/14/2002 | US20020031549 Side effect reduction; antiepideptic agents, headaches, bipolar disorders |
| 03/14/2002 | US20020031548 Pharmaceutical compositions of estrogenic agents |
| 03/14/2002 | US20020031547 Immediately disintegrable medicinal composition |
| 03/14/2002 | US20020031546 Subcoated simulated capsule-like medicament |
| 03/14/2002 | US20020031545 Sustained-release preparation |
| 03/14/2002 | US20020031544 Antiinflammatory agents |
| 03/14/2002 | US20020031542 Isoprene styrene block copolymer, a rosin-based resin, a plasticizer, polyisobutylene, an antioxidant; bandages |
| 03/14/2002 | US20020031541 Feed supplement to a ruminant animal; antifoam, wetting and surfactant agents |
| 03/14/2002 | US20020031527 Bulking agents, cryoprotectants and lyoprotectants added for storage stability |
| 03/14/2002 | US20020031515 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
| 03/14/2002 | US20020031502 Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers |
| 03/14/2002 | US20020031480 Aerosolizing a hydrofluoroalkane (HFA)/THC composition to provide droplets respirable by a lung of a patient, and administering; inhalers; treating pain, cachexia, migraines, nausea,muscle spasticity |
| 03/14/2002 | US20020031479 Medicaments |
| 03/14/2002 | US20020031477 Biomedical assay device |
| 03/14/2002 | US20020031476 Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement |
| 03/14/2002 | DE10128266A1 Verfahren zur Herstellung eines Extrakts mit starker Antiinflammations-Antiblutplättchenaggregations- und Antifungi-Aktivität aus Zingiber officinale und pharmazeutische Zusammensetzungen, die diesen Extrakt enthalten A process for preparing an extract with a strong Antiinflammations-Antiblutplättchenaggregations- and antifungal activity of Zingiber officinale and pharmaceutical compositions containing this extract |
| 03/14/2002 | DE10043509A1 Feste Peptidzubereitungen für die Inhalation und deren Herstellung Fixed peptide preparations for inhalation and their preparation |
| 03/14/2002 | DE10042833A1 Feste Zubereitungen mit einer Multi-Kern Struktur Solid preparations with a multi-core structure |
| 03/14/2002 | DE10041479A1 Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923 Novel pharmaceutical composition for the administration of N-0923 |
| 03/14/2002 | DE10041478A1 Neue pharmazeutische Zusammensetzung New pharmaceutical composition |
| 03/14/2002 | DE10030378A1 Neue pharmazeutische Zusammensetzung zur topischen Anwendung von wasserunlöslichen und/oder schwer wasserlöslichen Wirkstoffen New pharmaceutical composition for topical application of water-insoluble and / or poorly water-soluble drugs |
| 03/14/2002 | CA2771723A1 Devices, systems and methods for patient infusion |